Vocal Biomarkers Market Research Report- Global Forecast till 2027

Vocal Biomarkers Market information: by type (frequency, amplitude, error rate, vocal rise or fall time, phonation time, voice tremor, pitch, others) by indications (psychiatric disorders (depression, Attention Deficit and Disruptive Behavior Disorders, others), neurological disorders (Parkinson's disease (PD), Alzheimer's disease, Huntington's disease, others), Respiratory Disorders, Cardiovascular Disorders, traumatic brain injury (TBI), others), others) by end users (hospitals and clinics, academic and research, others) - Global Forecast till 2027

ID: MRFR/LS/2631-HCR | February 2021 | Region: Global | 90 pages

Please note that the assessment period of report has been updated from 2017-2023 to 2020-2027. Cordially fill the sample form for updated data.


Market Synopsis of Global Vocal biomarkers Market:


Market scenario:


Vocal biomarkers are used as a non-invasive method to detect diseases by using speech characteristics. Its application is based on the fact that major psycological disorder, neurophysiologic changes etc. affect motor control and therefore alter speech production by influencing the characteristics of the speech.


The market for vocal biomarkers is driven by factors such as growing prevalence of psychological, neurological and other diseases affecting speech such as depression, Attention Deficit and Disruptive Behavior Disorders, Parkinson's disease (PD), Alzheimer's disease, Huntington's disease, Respiratory and Cardiovascular Disorders, traumatic brain injury (TBI) etc.


Considering all these factors the market for vocal biomarkers is expected to reach $ 2.5 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 14.5 % during 2017-2023.


Study objectives:



  • To provide a detailed analysis of the market structure along with estimated future growth forecast for the next six years about various segments and sub-segments of the global vocal biomarkers market

  • To provide insights about factors affecting the market growth

  • To analyze the global vocal biomarkers market based on various factors - Price Analysis, Supply Chain Analysis, Porter’s Five Force analysis etc.

  • To provide past and estimated future revenue of the market’s segments and sub-segments with respect to four main geographies and their countries - the Americas, Europe, Asia Pacific along with Middle East & Africa

  • To provide country level analysis of the market with respect to the current market size and future growth prospects

  • To provide country level analysis of the market which includes segmentation by type, indications and end users.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape of the market

  • To track and analyze developments which are competitive in nature such as joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments that are currently taking place in the global vocal biomarkers markets


Research methodology  
        
Research methodology vocal biomarkers markets                                                                           


Sources: Mayo Clinic, MRFR Analysis.


Intended Audience



  • Global Vocal biomarkers, manufacturers & suppliers

  • Research and development (R&D) companies

  • Market research and consulting service providers

  • Academic institutes and universities


 


Figure 1         Global Vocal biomarkers Market by Indications, 2016 (% Market Share)
Vocal biomarkers Market by Indications, 2016 (% Market Share)


Segments:


The global vocal biomarkers market is segmented on the basis of type, indications and end users. Based on type, the market has been segmented as frequency, amplitude, error rate, vocal rise or fall time, phonation time, voice tremor, pitch and others. Based on the indications, the market has been segmented as psychiatric disorders (depression, attention deficit and disruptive behavior disorders, others), neurological disorders (Parkinson’s disease (PD), Alzheimer's disease, Huntington's disease, others), respiratory disorders, cardiovascular disorders, traumatic brain injury (TBI), others) and others. Based on the end users, the market has been segmented as hospitals and clinics, academic and research and others.


Regional analysis


US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. The faster market uptake of new technology in the US is also an important driver of the market for global vocal biomarkers. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is expected to have the most future potential and it is estimated to be led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The regions of Africa are expected to witness a moderate growth due to poor economic and political conditions and poor healthcare penetration.


Key players of Global Vocal biomarkers Market:


Key players profiled in the report are Beyond Verbal, Sonde Health, Audio Profiling, IBM Corporation, Cogito Corporation and others.

The report for Global Vocal Biomarkers Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.



Table of contents

1. Introduction

1.1 Definition

1.2 scope of study

1.2.1 Research Objective

1.2.2 Assumptions & Limitations

1.2.2.1 Assumptions

1.2.2.2 Limitations

1.3 Market Structure:

2. Research Methodology

2.1 Research Process:

2.2 Primary Research

2.3 Secondary Research:

3. Market dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Macroeconomic Indicators

4. Market factor analysis

4.1 Porters Five Forces Model

4.2 Bargaining Power Of Suppliers

4.3 Bargaining Power Of Buyers

4.4 Threat Of New Entrants

4.5 Threat Of Substitutes

4.6 Intensity Of Rivalry

5. Global vocal biomarkers market, by Type

5.1 Frequency

5.2 Amplitude

5.3 Error Rate

5.4 Vocal Rise or Fall Time

5.5 Phonation Time

5.6 Voice Tremor

5.7 Pitch

5.8 Others

6. Global Vocal Biomarkers Market, By Diagnosis

6.1 Introduction

6.2 Psychiatric Disorders

6.2.1 Depression

6.2.2 Attention Deficit and Disruptive Behavior Disorders

6.2.3 Others

6.3 Neurological Disorders

6.3.1 Parkinson's Disease (PD)

6.3.2 Alzheimer's Disease

6.3.3 Huntington's Disease

6.3.4 Others

6.4 Respiratory Disorders

6.5 Cardiovascular Disorders

6.6 Traumatic Brain Injury (TBI)

6.7 Others

7. Global Vocal Biomarkers Market, By End Users

7.1 Hospitals And Clinics

7.2 Academic And Research

7.3 Others

8. Global Vocal Biomarkers Market, By Region

8.1 North America

8.1.1 Introduction

8.2 Europe

8.2.1 Introduction

8.3 Asia-Pacific

8.3.1 Introduction

8.4 Middle East & Africa

8.4.1 Introduction

9. Competitive landscape

9.1 Major Strategies Adopted By Market Players

9.1.1 Strategic Partnership

9.1.2 Merger & Acquisition

10. Company profile

10.1 Beyond Verbal

10.1.1 Overview

10.1.2 Product Overview

10.1.3 Financials

10.1.4 Key Developments

10.2 Sonde Health

10.2.1 Overview

10.2.2 Product Overview

10.2.3 Financials

10.2.4 Key Developments

10.3 Audio Profiling

10.3.1 Overview

10.3.2 Product Overview

10.3.3 Financials

10.3.4 Key Development

10.4 IBM Corporation

10.4.1 Overview

10.4.2 Product Overview

10.4.3 Financials

10.4.4 Key Developments

10.5 Cogito Corporation

10.5.1 Overview

10.5.2 Product Overview

10.5.3 Financials

10.5.4 Key Developments

10.6 Others


Conclusion


11.1 Key Findings

11.1.1 From Ceo’s Viewpoint

11.1.2 Unmet Needs Of The Market

11.2 Key Companies To Watch

11.3 Prediction Of Vocal Biomarkers Industry

12. Appendix